Targeting Glia Cells: Novel Perspectives for the Treatment of Neuropsychiatric Diseases

Author(s): B. Di Benedetto, R. Rupprecht

Journal Name: Current Neuropharmacology

Volume 11 , Issue 2 , 2013

Become EABM
Become Reviewer
Call for Editor


Neuropsychiatric disorders are devastating mental illnesses with a high economic burden. The additional morbidity associated with social issues that arises along with the course of these diseases increases the need for a clear understanding of their etiopathogenesis to allow an implementation of novel pharmacological strategies. Yet a poor knowledge about interactions occurring at the glia-neuron interface in health and disease still hampers innovative discoveries, despite the fact that glia cells have been long described to actively participate in the regulation of brain circuits.

The purpose of this review was to collect the scattered literature on the involvement of glia cells in neuropsychiatric disorders and to describe how also these cells besides neurons might be responsive to current pharmacological interventions. We hope thereby to offer alternative approaches for investigations that may open avenues to search for new potential targets for drug discovery.

Keywords: Astrocytes, microglia, neuropsychiatric disorders, oligodendrocytes, pharmacotherapy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [171 - 185]
Pages: 15
DOI: 10.2174/1570159X11311020004
Price: $65

Article Metrics

PDF: 8